ETC
ADPT icon

Exchange Traded Concepts’s Adaptive Biotechnologies ADPT Stock Holding History

Exchange Traded Concepts’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
57,443
-4,306
-7% -$66K 0.01% 863
2026
Q1 		$857K Sell
61,749
-1,659
-3% -$26.4K 0.01% 873
2025
Q4 		$1.03M Sell
63,408
-765
-1% -$12.5K 0.01% 794
2025
Q3 		$960K Sell
64,173
-9,458
-13% -$115K 0.01% 792
2025
Q2 		$858K Sell
73,631
-11,646
-14% -$106K 0.01% 735
2025
Q1 		$634K Buy
+85,277
New +$655K 0.01% 750
2021
Q2 		– Sell
-231
Closed -$9K – 1096
2021
Q1 		$9K Sell
231
-215
-48% -$11.6K ﹤0.01% 988
2020
Q4 		$26K Buy
+446
New +$23K ﹤0.01% 811

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Exchange Traded Concepts's ADPT Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Adaptive Biotechnologies (ADPT) stake by 7% in Q2 2026, selling an estimated $66K and leaving 57,443 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #863.

Exchange Traded Concepts first reported a position in ADPT in Q4 2020 and has held it in 8 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Exchange Traded Concepts held 57,443 shares of Adaptive Biotechnologies worth $1.23M as of Q2 2026.
  • Exchange Traded Concepts sold 4,306 Adaptive Biotechnologies shares in Q2 2026, an estimated $66K.
  • Adaptive Biotechnologies made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #863 holding.
  • Exchange Traded Concepts first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 8 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.